Sale!

SFXN4 Gene Combined Oxidative Phosphorylation Deficiency Type 18 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The SFXN4 Gene Combined Oxidative Phosphorylation Deficiency Type 18 NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the SFXN4 gene responsible for this rare metabolic disorder. Using next-generation sequencing technology, this test provides precise detection of genetic variants affecting mitochondrial function and energy production. Patients experiencing unexplained neurological symptoms, developmental delays, or metabolic abnormalities should consider this test for accurate diagnosis. The test costs $500 USD and includes pre-test genetic counseling to analyze family history and create detailed pedigree charts. Results are available within 3-4 weeks, providing crucial information for treatment planning and family genetic counseling.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

SFXN4 Gene Combined Oxidative Phosphorylation Deficiency Type 18 NGS Genetic DNA Test

Understanding Combined Oxidative Phosphorylation Deficiency Type 18

Combined Oxidative Phosphorylation Deficiency Type 18 is a rare inherited metabolic disorder caused by mutations in the SFXN4 gene, which plays a critical role in mitochondrial function and cellular energy production. This condition affects the body’s ability to generate adenosine triphosphate (ATP), the primary energy currency of cells, leading to multi-system complications primarily involving neurological and muscular systems.

What This Test Measures and Detects

Our advanced NGS Genetic DNA Test specifically analyzes the SFXN4 gene to identify pathogenic variants responsible for Combined Oxidative Phosphorylation Deficiency Type 18. The test provides comprehensive coverage of:

  • Complete sequencing of the SFXN4 gene coding regions
  • Detection of point mutations, insertions, and deletions
  • Analysis of splice site variants affecting gene expression
  • Identification of both inherited and de novo mutations

Who Should Consider This Test

This genetic test is recommended for individuals presenting with symptoms suggestive of mitochondrial disorders, including:

  • Unexplained neurological symptoms such as seizures or developmental regression
  • Progressive muscle weakness and exercise intolerance
  • Developmental delays in motor skills and cognitive function
  • Metabolic abnormalities including lactic acidosis
  • Family history of similar symptoms or confirmed mitochondrial disorders
  • Infants and children with failure to thrive and multisystem involvement

Benefits of SFXN4 Gene Testing

Early and accurate diagnosis through genetic testing provides numerous advantages:

  • Precise Diagnosis: Confirms or rules out Combined Oxidative Phosphorylation Deficiency Type 18
  • Treatment Guidance: Enables targeted therapeutic interventions and management strategies
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Prognostic Information: Helps predict disease progression and potential complications
  • Research Contribution: Advances understanding of rare metabolic disorders

Understanding Your Test Results

Our comprehensive genetic counseling services help you interpret your results effectively:

  • Positive Result: Indicates the presence of pathogenic SFXN4 gene mutations, confirming diagnosis and guiding treatment approaches
  • Negative Result: Suggests that SFXN4 mutations are not the cause of symptoms, directing further diagnostic evaluation
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications, requiring ongoing monitoring and research
  • Carrier Status: Determines if individuals carry one copy of a mutated gene without showing symptoms

Test Details and Pricing

Test Feature Details
Test Name SFXN4 Gene Combined Oxidative Phosphorylation Deficiency Type 18 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

To ensure accurate results and comprehensive care, we require:

  • Complete clinical history of the patient undergoing testing
  • Genetic counseling session to create detailed pedigree chart of family members affected by Combined Oxidative Phosphorylation Deficiency Type 18
  • Informed consent for genetic testing and result interpretation

Nationwide Testing Availability

We provide comprehensive genetic testing services across the United States with convenient locations in major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and medical professionals ensures you receive expert care regardless of your location.

Take Control of Your Genetic Health Today

Don’t let uncertainty about potential genetic disorders affect your quality of life. Our SFXN4 Gene Combined Oxidative Phosphorylation Deficiency Type 18 NGS Genetic DNA Test provides the clarity you need for informed medical decisions and comprehensive family planning.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our dedicated team is ready to guide you through every step of the testing process and help you understand your genetic health.